Mergers & Acquisitions ·
Beacon Topco amends merger agreement to set closing date for Nov. 13
CLYDBeacon Topco, Inc.
Beacon Topco, Inc., Barinthus Biotherapeutics plc, and Clywedog Therapeutics entered into a Third Amendment to their Merger Agreement on October 31, 2026. The amendment restates the closing timeline, requiring the transaction to close by November 13, 2026, and updates the definition of the "End Date" accordingly. This follows previous amendments dated February 22 and September 22, 2026, and the acquisition of Beacon's share capital via a scheme of arrangement approved in September. The deal involves Merger Sub merging with Clywedog, which will continue as a wholly owned subsidiary of Topco. Beacon Topco operates in the biotechnology sector.